Folic Acid Functionalized AQ4N/Gd@PDA Nanoplatform with Real-Time Monitoring of Hypoxia Relief and Enhanced Synergistic Chemo/Photothermal Therapy in Glioma

References

• Dumas AA, Pomella N, Rosser G, et al. Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment. EMBO J. 2020;39(15):e103790. doi:10.15252/embj.2019103790
   PubMed Web of Science ®Google Scholar
• Carlsson SK, Brothers SP, Wahlestedt C. Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med. 2014;6(11):1359–1370. doi:10.15252/emmm.201302627
   PubMed Web of Science ®Google Scholar
• Batash R, Asna N, Schaffer P, et al. Glioblastoma multiforme, diagnosis and treatment; recent literature review. Curr Med Chem. 2017;24(27):3002–3009. doi:10.2174/0929867324666170516123206
   PubMed Web of Science ®Google Scholar
• McMahon DJ, Gleeson JP, O’Reilly S, et al. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches. Med Oncol. 2022;39(9):129. doi:10.1007/s12032-022-01708-w
   PubMed Web of Science ®Google Scholar
• Fan Y, Sun Y, Chang W, et al. Bioluminescence imaging and two-photon microscopy guided laser ablation of GBM decreases tumor burden. Theranostics. 2018;8(15):4072–4085. doi:10.7150/thno.25357
   PubMed Web of Science ®Google Scholar
• Dai X, Shao Y, Tian X, et al. Fusion between glioma stem cells and mesenchymal stem cells promotes malignant progression in 3D-bioprinted models. ACS Appl Mater Interfaces. 2022;14(31):35344–35356. doi:10.1021/acsami.2c06658
   PubMed Web of Science ®Google Scholar
• Yang J, Shi Z, Liu R, et al. Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology. Theranostics. 2020;10(7):3223–3239. doi:10.7150/thno.40298
   PubMed Web of Science ®Google Scholar
• Dai XL, Ye L, Li HX, et al. Crosstalk between microglia and neural stem cells influences the relapse of glioblastoma in GBM immunological microenvironment. Clin Immunol. 2023;251:109333. doi:10.1016/j.clim.2023.109333
   PubMed Web of Science ®Google Scholar
• Saran F, Welsh L, James A, et al. Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a Phase I trial. J Neuro-oncol. 2021;155(3):307–317. doi:10.1007/s11060-021-03877-6
   PubMed Web of Science ®Google Scholar
• El-khayat SM, Arafat WO. Therapeutic strategies of recurrent glioblastoma and its molecular pathways ‘Lock up the beast’. Ecancermedicalscience. 2021;15:1176. doi:10.3332/ecancer.2021.1176
   PubMed Web of Science ®Google Scholar
• Nguyen H-M, Guz-Montgomery K, Lowe DB, et al. Pathogenetic features and current management of glioblastoma. Cancers. 2021;13(4):856. doi:10.3390/cancers13040856
   PubMed Web of Science ®Google Scholar
• Gote V, Nookala AR, Bolla PK, et al. Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue. Int J Mol Sci. 2021;22(9):4673. doi:10.3390/ijms22094673
   PubMed Web of Science ®Google Scholar
• Li B, Jiang J, Assaraf YG, et al. Surmounting cancer drug resistance: new insights from the perspective of N6-methyladenosine RNA modification. Drug Resist Updates. 2020;53:100720. doi:10.1016/j.drup.2020.100720
   PubMed Web of Science ®Google Scholar
• Rani V, Deep G, Singh RK, Palle K, Yadav UCS. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183–193. doi:10.1016/j.lfs.2016.02.002
   PubMed Web of Science ®Google Scholar
• Gammon L, Mackenzie IC. Roles of hypoxia, stem cells and epithelial–mesenchymal transition in the spread and treatment resistance of head and neck cancer. J Oral Pathol Med. 2015;45(2):77–82. doi:10.1111/jop.12327
   PubMed Web of Science ®Google Scholar
• Muzi M, Wolsztynski E, Fink JR, et al. Assessment of the prognostic value of radiomic features in 18F-FMISO PET imaging of hypoxia in postsurgery brain cancer patients: secondary analysis of imaging data from a single-center study and the multicenter ACRIN 6684 trial. Tomography. 2020;6(1):14–22. doi:10.18383/j.tom.2019.00023
   PubMedGoogle Scholar
• Laurenti G, Benedetti E, D’Angelo B, et al. Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells. J Cell Biochem. 2011;112(12):3891–3901. doi:10.1002/jcb.23323
   PubMed Web of Science ®Google Scholar
• Rashid M, Zadeh LR, Baradaran B, et al. Up-down regulation of HIF-1α in cancer progression. Gene. 2021;798:145796. doi:10.1016/j.gene.2021.145796
   PubMed Web of Science ®Google Scholar
• Qiu L-Y, Chen H-P, Yan Y-F, et al. Sasanquasaponin promotes cellular chloride efflux and elicits cardioprotection via the PKCε pathway. Mol Med Rep. 2016;13(4):3597–3603. doi:10.3892/mmr.2016.4984
   PubMed Web of Science ®Google Scholar
• Chen Z, Han F, Du Y, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70. doi:10.1038/s41392-023-01332-8
   PubMed Web of Science ®Google Scholar
• Persano L, Pistollato F, Rampazzo E, et al. BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression. Cell Death Dis. 2012;3(10):e412–e412. doi:10.1038/cddis.2012.153
   PubMedGoogle Scholar
• Song L, Wang G, Hou X, et al. Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer. Acta Biomater. 2020;108:313–325. doi:10.1016/j.actbio.2020.03.034
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang Z, Xiong Y, et al. A two-pronged strategy to alleviate tumor hypoxia and potentiate photodynamic therapy by mild hyperthermia. Biomater Sci. 2023;11(1):108–118. doi:10.1039/D2BM01691E
   Web of Science ®Google Scholar
• Du C, Wu X, He M, et al. Polymeric photothermal agents for cancer therapy: recent progress and clinical potential. J Mat Chem B. 2021;9(6):1478–1490. doi:10.1039/D0TB02659J
   PubMed Web of Science ®Google Scholar
• Chen Y, Meng W, Chen M, et al. Biotin-decorated hollow gold nanoshells for dual-modal imaging-guided NIR-II photothermal and radiosensitizing therapy toward breast cancer. J Mat Chem B. 2023;11(41):10003–10018. doi:10.1039/D3TB01736B
   PubMed Web of Science ®Google Scholar
• Liu D, Dai X, Zhang W, et al. Liquid exfoliation of ultrasmall zirconium carbide nanodots as a noninflammatory photothermal agent in the treatment of glioma. Biomaterials. 2023;292:121917. doi:10.1016/j.biomaterials.2022.121917
   PubMed Web of Science ®Google Scholar
• Zhao S, Yan L, Cao M, et al. Near-infrared light-triggered lysosome-targetable carbon dots for photothermal therapy of cancer. ACS Appl Mater Interfaces. 2021;13(45):53610–53617. doi:10.1021/acsami.1c15926
   PubMed Web of Science ®Google Scholar
• Zeng Y, Zhao L, Li K, et al. Aptamer-functionalized nanoplatforms overcoming temozolomide resistance in synergistic chemo/photothermal therapy through alleviating tumor hypoxia. Nano Res. 2023;16(7):9859–9872. doi:10.1007/s12274-023-5742-7
   Web of Science ®Google Scholar
• Tian B, Wang C, Du Y, et al. Near infrared-triggered theranostic nanoplatform with controlled release of HSP90 inhibitor for synergistic mild photothermal and enhanced nanocatalytic therapy with hypoxia relief. Small. 2022;18(28):2200786. doi:10.1002/smll.202200786
   PubMed Web of Science ®Google Scholar
• Zeng Y, Chang P, Ma J, et al. DNA origami–anthraquinone hybrid nanostructures for in vivo quantitative monitoring of the progression of tumor hypoxia affected by chemotherapy. ACS Appl Mater Interfaces. 2022;14(5):6387–6403. doi:10.1021/acsami.1c22620
   PubMed Web of Science ®Google Scholar
• Chen D, Wang W, Zhu Q, et al. In vivo real-time monitoring of the development of hypoxia and angiogenesis in cervical cancer. Chem Eng J. 2023;473:145498. doi:10.1016/j.cej.2023.145498
   Web of Science ®Google Scholar
• Zhu H, Huang C, Di J, et al. Doxorubicin-Fe(III)-Gossypol Infinite Coordination Polymer@PDA: CuO2 composite nanoparticles for cost-effective programmed photothermal-chemodynamic-coordinated dual drug chemotherapy trimodal synergistic tumor therapy. ACS Nano. 2023;17(13):12544–12562. doi:10.1021/acsnano.3c02401
   PubMed Web of Science ®Google Scholar
• Wang J, Liu L, You Q, et al. All-in-one theranostic nanoplatform based on hollow MoSx for photothermally-maneuvered oxygen self-enriched photodynamic therapy. Theranostics. 2018;8(4):955–971. doi:10.7150/thno.22325
   PubMedGoogle Scholar
• Sun T, Li J, Zeng C, et al. Banoxantrone coordinated metal−organic framework for photoacoustic imaging-guided high intensity focused ultrasound therapy. Adv Healthc Mater. 2022;12(2):2202348. doi:10.1002/adhm.202202348
   Web of Science ®Google Scholar
• Feshitan JA, Vlachos F, Sirsi SR, et al. Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery. Biomaterials. 2012;33(1):247–255. doi:10.1016/j.biomaterials.2011.09.026
   PubMed Web of Science ®Google Scholar